Showing results (1711-1720 of 1,730) with videos related to
Sort By:
Pageof 173
Journal of Hematology & Oncology|July 30, 2021
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelinNengzhi Pang, Jingxuan Shi, Le Qin, et al.Molecular Plant|October 17, 2022
Overproduction of OsRACK1A, an effector-targeted scaffold protein promoting OsRBOHB-mediated ROS production, confers rice floral resistance to false smut disease without yield penaltyGuo-Bang Li, Jia-Xue He, Jin-Long Wu, et al.Nature Medicine|May 13, 2024
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancerYue Zeng, Chun-Hong Hu, Yi-Zheng Li, et al.Science Advances|August 9, 2020
From asymmetrical to balanced genomic diversification during rediploidization: Subgenomic evolution in allotetraploid fishJing Luo, Jing Chai, Yanling Wen, et al.The Plant Cell|February 1, 2024
Rice false smut virulence protein subverts host chitin perception and signaling at lemma and palea for floral infectionGuo-Bang Li, Jie Liu, Jia-Xue He, et al.Biomedical and Environmental Sciences : BES|January 4, 2023
3- to 24-month Follow-up on COVID-19 with Pulmonary Tuberculosis Survivors after Discharge: Results from a Prospective, Multicenter StudyJing Ya Wang, Xing Yu Zong, Gui Hui Wu, et al.Translational Lung Cancer Research|May 20, 2021
Is flexible bronchoscopy necessary in the preoperative workup of patients with peripheral cT1N0 subsolid lung cancer? -a prospective multi-center cohort studyTing Ye, Zongwei Chen, Dongchun Ma, et al.Annals of Internal Medicine|June 19, 2023
Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 <b>×</b> 2 Factorial TrialXiao-Ke Wu, Jing-Shu Gao, Hong-Li Ma, et al.Blood|July 24, 2024
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APLXiaosu Zhou, Xue Chen, Jiaqi Chen, et al.National Science Review|December 1, 2025
Homoharringtonine is highly effective against SARS-CoV-2: a potential first-line defense in future coronavirus epidemicsHai-Jun Wen, Hua-Juan Ma, Gong-Xun Zhong, et al.Pageof 173